Home › Funds › Parkman Healthcare Partners LLC › INDV

Parkman Healthcare Partners LLC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Parkman Healthcare Partners LLC reported holding 521,580 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 1.69% of its reported portfolio and ranking #17 among its reported holdings. Parkman Healthcare Partners LLC has disclosed INDV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)521.58K sh
Reported value held$18.70M
Portfolio Weight1.69%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's INDV position evolved

Parkman Healthcare Partners LLC first disclosed a stake in INDV in Q2 2026 at 364,269 shares (US$14.9M). The position peaked in Q3 2026 at 521,580 shares, worth US$18.7M. Across 2 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 521,580 shares valued at US$18.7M — an increase of 157,311 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 364.27K $14.95M New
Q3 2026 521.58K $18.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$173.9M), Two Seas Capital LP (US$131.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held INDV?

Parkman Healthcare Partners LLC has disclosed INDV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Parkman Healthcare Partners LLC's current position in INDV?

As of Q3 2026, Parkman Healthcare Partners LLC holds 521.58K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $18.70M, representing 1.69% of its reported portfolio and ranking #17.

Has Parkman Healthcare Partners LLC been buying or selling INDV?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in INDV. The position peaked in Q3 2026 at 521.58K shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, Two Seas Capital LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.